Fresh whole blood was obtained from 8 healthy donors (HD), 8 SLE, and 7 SjS patients under an approved IRB protocol. Patients were recruited from the University of Washington Medical Center. For SLE, disease activity was measured using the SLE Disease Activity Index 2000 (SLEDAI-2K). Patients treated with biologics within the last 6 months or suspected of having acute infections were excluded from the analysis. HD with no history of autoimmune diseases or current infections were used. Additional information about the SjS and SLE study subjects included in the analysis is shown in Supplemental Table 1.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.